227 related articles for article (PubMed ID: 32152452)
21. Human chorionic gonadotropin-dependent expression of vascular endothelial growth factor/vascular permeability factor in human granulosa cells: importance in ovarian hyperstimulation syndrome.
Neulen J; Yan Z; Raczek S; Weindel K; Keck C; Weich HA; Marmé D; Breckwoldt M
J Clin Endocrinol Metab; 1995 Jun; 80(6):1967-71. PubMed ID: 7775647
[TBL] [Abstract][Full Text] [Related]
22. BMP6 increases TGF-β1 production by up-regulating furin expression in human granulosa-lutein cells.
Zhang XY; Chang HM; Zhu H; Liu RZ; Leung PCK
Cell Signal; 2019 Mar; 55():109-118. PubMed ID: 30633987
[TBL] [Abstract][Full Text] [Related]
23. The Dual Role of PEDF in the Pathogenesis of OHSS: Negating Both Angiogenic and Inflammatory Pathways.
Miller I; Chuderland D; Grossman H; Ron-El R; Ben-Ami I; Shalgi R
J Clin Endocrinol Metab; 2016 Dec; 101(12):4699-4709. PubMed ID: 27680872
[TBL] [Abstract][Full Text] [Related]
24. Signal mechanisms of vascular endothelial growth factor and interleukin-8 in ovarian hyperstimulation syndrome: dopamine targets their common pathways.
Chen SU; Chou CH; Lin CW; Lee H; Wu JC; Lu HF; Chen CD; Yang YS
Hum Reprod; 2010 Mar; 25(3):757-67. PubMed ID: 20008399
[TBL] [Abstract][Full Text] [Related]
25. sRAGE downregulates the VEGF expression in OHSS ovarian granulosa cells.
Wang B; Wang J; Liu Y; Wang L; Du M; Zhang Z; Guan Y
Gynecol Endocrinol; 2021 Sep; 37(9):836-840. PubMed ID: 34223781
[TBL] [Abstract][Full Text] [Related]
26. Kisspeptin-10 inhibits OHSS by suppressing VEGF secretion.
Zhai J; Liu J; Zhao S; Zhao H; Chen ZJ; Du Y; Li W
Reproduction; 2017 Oct; 154(4):355-362. PubMed ID: 28676533
[TBL] [Abstract][Full Text] [Related]
27. TGF-β1 promotes hyaluronan synthesis by upregulating hyaluronan synthase 2 expression in human granulosa-lutein cells.
Wang F; Chang HM; Yi Y; Li H; Leung PCK
Cell Signal; 2019 Nov; 63():109392. PubMed ID: 31437481
[TBL] [Abstract][Full Text] [Related]
28. Dopamine receptor 2 activation inhibits ovarian vascular endothelial growth factor secretion in vitro: implications for treatment of ovarian hyperstimulation syndrome with dopamine receptor 2 agonists.
Ferrero H; García-Pascual CM; Gómez R; Delgado-Rosas F; Cauli O; Simón C; Gaytán F; Pellicer A
Fertil Steril; 2014 May; 101(5):1411-8. PubMed ID: 24581579
[TBL] [Abstract][Full Text] [Related]
29. TGFβ1 induces in-vitro and ex-vivo angiogenesis through VEGF production in human ovarian follicular fluid-derived granulosa cells during in-vitro fertilization cycle.
Lai TH; Chen HT; Wu WB
J Reprod Immunol; 2021 Jun; 145():103311. PubMed ID: 33812317
[TBL] [Abstract][Full Text] [Related]
30. Involvement of the ANGPTs/Tie-2 system in ovarian hyperstimulation syndrome (OHSS).
Scotti L; Abramovich D; Pascuali N; de Zúñiga I; Oubiña A; Kopcow L; Lange S; Owen G; Tesone M; Parborell F
Mol Cell Endocrinol; 2013 Jan; 365(2):223-30. PubMed ID: 23123737
[TBL] [Abstract][Full Text] [Related]
31. Zinc finger gene 217 (ZNF217) Promoted Ovarian Hyperstimulation Syndrome (OHSS) through Regulating E
Zhai J; Liu J; Cheng X; Li S; Hong Y; Sun K; Chen ZJ; Du Y; Li W
Sci Rep; 2017 Jun; 7(1):3245. PubMed ID: 28607476
[TBL] [Abstract][Full Text] [Related]
32. Higher melatonin in the follicle fluid and MT2 expression in the granulosa cells contribute to the OHSS occurrence.
Li Y; Fang L; Yu Y; Shi H; Wang S; Guo Y; Sun Y
Reprod Biol Endocrinol; 2019 Apr; 17(1):37. PubMed ID: 30979376
[TBL] [Abstract][Full Text] [Related]
33. Effect of kisspeptin-54 on ovarian levels of pigment epithelium-derived factor (PEDF) and vascular endothelial growth factor (VEGF) in an experimental model of ovarian hyperstimulation syndrome (OHSS).
Birinci H; Vatansever HS; Yüncü M
Reprod Fertil Dev; 2021 Nov; 33(16):799-809. PubMed ID: 34610858
[TBL] [Abstract][Full Text] [Related]
34. Exosomal miR-27 negatively regulates ROS production and promotes granulosa cells apoptosis by targeting SPRY2 in OHSS.
Liu K; Yang W; Hu M; Xie W; Huang J; Cui M; He X; Nie X
J Cell Mol Med; 2021 Apr; 25(8):3976-3990. PubMed ID: 33638619
[TBL] [Abstract][Full Text] [Related]
35. Dopamine receptor 2 activation inhibits ovarian vascular endothelial growth factor secretion in an ovarian hyperstimulation syndrome (OHSS) animal model: implications for treatment of OHSS with dopamine receptor 2 agonists.
Ferrero H; García-Pascual CM; Gaytán M; Morales C; Simón C; Gaytán F; Pellicer A; Gómez R
Fertil Steril; 2014 Nov; 102(5):1468-1476.e1. PubMed ID: 25217874
[TBL] [Abstract][Full Text] [Related]
36. Human albumin enhances expression of vascular endothelial growth factor in cultured human luteinizing granulosa cells: importance in ovarian hyperstimulation syndrome.
Doldi N; Destefani A; Gessi A; Grossi D; Ferrari A
Hum Reprod; 1999 May; 14(5):1157-9. PubMed ID: 10325253
[TBL] [Abstract][Full Text] [Related]
37. ID3 mediates the TGF-β1-induced suppression of matrix metalloproteinase-1 in human granulosa cells.
Li H; Chang HM; Shi Z; Leung PCK
FEBS J; 2019 Nov; 286(21):4310-4327. PubMed ID: 31215762
[TBL] [Abstract][Full Text] [Related]
38. Administration of a gonadotropin-releasing hormone agonist affects corpus luteum vascular stability and development and induces luteal apoptosis in a rat model of ovarian hyperstimulation syndrome.
Scotti L; Irusta G; Abramovich D; Tesone M; Parborell F
Mol Cell Endocrinol; 2011 Mar; 335(2):116-25. PubMed ID: 21238536
[TBL] [Abstract][Full Text] [Related]
39. Local VEGF inhibition prevents ovarian alterations associated with ovarian hyperstimulation syndrome.
Scotti L; Abramovich D; Pascuali N; Irusta G; Meresman G; Tesone M; Parborell F
J Steroid Biochem Mol Biol; 2014 Oct; 144 Pt B():392-401. PubMed ID: 25151950
[TBL] [Abstract][Full Text] [Related]
40. A potential role of endoplasmic reticulum stress in development of ovarian hyperstimulation syndrome.
Takahashi N; Harada M; Hirota Y; Zhao L; Yoshino O; Urata Y; Izumi G; Takamura M; Hirata T; Koga K; Wada-Hiraike O; Fujii T; Osuga Y
Mol Cell Endocrinol; 2016 Jun; 428():161-9. PubMed ID: 27032713
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
